| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.643 | 0.031 | 0.643 | Caspase 9 stimulant | 0.642 0.031 DBMET00829 | ||
| 0.607 | 0.005 | 0.607 | Calcium channel L-type activator | 0.586 0.007 DBMET00829 | ||
| 0.581 | 0.004 | 0.6 | Bronchodilator | 0.6 0.004 DBMET00829 | DBMET00829 | |
| 0.516 | 0.021 | 0.516 | Spasmolytic | 0.499 0.023 DBMET00829 | ||
| 0.471 | 0.038 | 0.471 | Toll-Like receptor agonist | 0.291 0.117 DBMET00829 | ||
| 0.462 | 0.04 | 0.462 | Toll-Like receptor 7 agonist | 0.284 0.121 DBMET00829 | ||
| 0.466 | 0.05 | 0.521 | Transcription factor NF kappa B inhibitor | 0.521 0.041 DBMET00829 | DBMET00829 | |
| 0.457 | 0.064 | 0.507 | Cyclophilin D inhibitor | 0.507 0.048 DBMET00829 | DBMET00829 | |
| 0.442 | 0.052 | 0.442 | Antiobesity | 0.426 0.056 DBMET00829 | ||
| 0.407 | 0.022 | 0.466 | Calcium channel activator | 0.466 0.008 DBMET00829 | DBMET00829 | |
| 0.403 | 0.02 | 0.53 | Peroxidase inhibitor | 0.53 0.007 DBMET00829 | DBMET00829 | |
| 0.386 | 0.021 | 0.386 | Interleukin agonist | 0.383 0.021 DBMET00829 | ||
| 0.369 | 0.008 | 0.369 | Insulin sensitizer | 0.293 0.017 DBMET00829 | ||
| 0.359 | 0.01 | 0.605 | Antiadrenergic | 0.605 0.005 DBMET00829 | DBMET00829 | |
| 0.356 | 0.01 | 0.602 | Adrenaline antagonist | 0.602 0.005 DBMET00829 | DBMET00829 | |
| 0.414 | 0.07 | 0.528 | 5 Hydroxytryptamine release inhibitor | 0.528 0.025 DBMET00829 | DBMET00829 | |
| 0.402 | 0.06 | 0.402 | Calpain 2 inhibitor | 0.264 0.139 DBMET00829 | ||
| 0.342 | 0.014 | 0.342 | Peptidyltransferase inhibitor | 0.319 0.019 DBMET00829 | ||
| 0.373 | 0.045 | 0.43 | Vasodilator, coronary | 0.43 0.027 DBMET00829 | DBMET00829 | |
| 0.348 | 0.065 | 0.348 | Immunostimulant | 0.254 0.094 DBMET00829 | ||
| 0.327 | 0.056 | 0.327 | Sodium/bile acid cotransporter inhibitor | 0.299 0.08 DBMET00829 | ||
| 0.302 | 0.032 | 0.341 | Tyrosine 3 hydroxylase inhibitor | 0.341 0.018 DBMET00829 | DBMET00829 | |
| 0.308 | 0.041 | 0.351 | Psychostimulant | 0.351 0.031 DBMET00829 | DBMET00829 | |
| 0.278 | 0.018 | 0.326 | Nitric-oxide synthase stimulant | 0.326 0.007 DBMET00829 | DBMET00829 | |
| 0.297 | 0.049 | 0.297 | Interleukin antagonist | 0.186 0.092 DBMET00829 | ||
| 0.252 | 0.005 | 0.278 | Adrenaline agonist | 0.278 0.004 DBMET00829 | DBMET00829 | |
| 0.25 | 0.006 | 0.25 | Mucolytic | 0.238 0.008 DBMET00829 | ||
| 0.3 | 0.056 | 0.441 | Cardiotonic | 0.441 0.022 DBMET00829 | DBMET00829 | |
| 0.252 | 0.009 | 0.252 | Carbonic anhydrase III inhibitor | 0.246 0.01 DBMET00829 | ||
| 0.308 | 0.068 | 0.334 | Interleukin 2 agonist | 0.334 0.053 DBMET00829 | DBMET00829 | |
| 0.294 | 0.055 | 0.323 | Hypoglycemic | 0.323 0.045 DBMET00829 | DBMET00829 | |
| 0.252 | 0.012 | 0.252 | Expectorant | 0.251 0.013 DBMET00829 | ||
| 0.292 | 0.053 | 0.464 | Superoxide dismutase inhibitor | 0.464 0.017 DBMET00829 | DBMET00829 | |
| 0.284 | 0.048 | 0.284 | Amyloid beta aggregation inhibitor | 0.225 0.066 DBMET00829 | ||
| 0.254 | 0.019 | 0.259 | Anesthetic local | 0.259 0.018 DBMET00829 | DBMET00829 | |
| 0.312 | 0.078 | 0.312 | Apoptosis antagonist | 0.275 0.104 DBMET00829 | ||
| 0.315 | 0.089 | 0.36 | Vasodilator, peripheral | 0.36 0.07 DBMET00829 | DBMET00829 | |
| 0.283 | 0.057 | 0.283 | Antiamyloidogenic | 0.216 0.089 DBMET00829 | ||
| 0.301 | 0.078 | 0.301 | Caspase 3 stimulant | 0.291 0.084 DBMET00829 | ||
| 0.227 | 0.006 | 0.255 | Adenylate cyclase stimulant | 0.255 0.004 DBMET00829 | DBMET00829 | |
| 0.265 | 0.052 | 0.265 | Calpain inhibitor | 0.193 0.12 DBMET00829 | ||
| 0.22 | 0.015 | 0.333 | Carbonic anhydrase XV inhibitor | 0.333 0.006 DBMET00829 | DBMET00829 | |
| 0.219 | 0.023 | 0.219 | Adenylate cyclase inhibitor | 0.188 0.028 DBMET00829 | ||
| 0.259 | 0.066 | 0.259 | Angiogenesis stimulant | 0.187 0.101 DBMET00829 | ||
| 0.316 | 0.124 | 0.407 | Antibacterial | 0.407 0.074 DBMET00829 | DBMET00829 | |
| 0.205 | 0.017 | 0.208 | Cyclooxygenase 3 inhibitor | 0.208 0.016 DBMET00829 | DBMET00829 | |
| 0.267 | 0.086 | 0.481 | Hypoxia-inducible factor 1 alpha inhibitor | 0.481 0.016 DBMET00829 | DBMET00829 | |
| 0.187 | 0.008 | 0.361 | Phenylalanine 4-hydroxylase inhibitor | 0.361 0.003 DBMET00829 | DBMET00829 | |
| 0.181 | 0.004 | 0.22 | Beta adrenoreceptor antagonist | 0.22 0.004 DBMET00829 | DBMET00829 | |
| 0.178 | 0.003 | 0.187 | Diamine oxidase inhibitor | 0.187 0.003 DBMET00829 | DBMET00829 | |
| 0.187 | 0.012 | 0.187 | Urease inhibitor | 0.159 0.019 DBMET00829 | ||
| 0.204 | 0.032 | 0.25 | Monophenol monooxygenase inhibitor | 0.25 0.024 DBMET00829 | DBMET00829 | |
| 0.238 | 0.074 | 0.238 | Free radical scavenger | 0.227 0.079 DBMET00829 | ||
| 0.216 | 0.053 | 0.216 | Growth hormone agonist | 0.138 0.098 DBMET00829 | ||
| 0.271 | 0.11 | 0.304 | Antithrombotic | 0.304 0.085 DBMET00829 | DBMET00829 | |
| 0.173 | 0.014 | 0.173 | Aminoacyl-tRNA synthetase inhibitor | 0.152 0.018 DBMET00829 | ||
| 0.173 | 0.016 | 0.212 | Sphingomyelinase inhibitor | 0.212 0.008 DBMET00829 | DBMET00829 | |
| 0.186 | 0.03 | 0.186 | Toll-Like receptor 2 antagonist | 0.17 0.039 DBMET00829 | ||
| 0.155 | 0.005 | 0.205 | Beta 1 adrenoreceptor antagonist | 0.205 0.003 DBMET00829 | DBMET00829 | |
| 0.171 | 0.023 | 0.171 | Vanilloid 1 agonist | 0.148 0.04 DBMET00829 | ||
| 0.152 | 0.005 | 0.206 | Beta 3 adrenoreceptor antagonist | 0.206 0.004 DBMET00829 | DBMET00829 | |
| 0.198 | 0.053 | 0.198 | Thrombolytic | |||
| 0.189 | 0.046 | 0.219 | Protein kinase stimulant | 0.219 0.035 DBMET00829 | DBMET00829 | |
| 0.203 | 0.062 | 0.323 | P-glycoprotein inhibitor | 0.323 0.025 DBMET00829 | DBMET00829 | |
| 0.226 | 0.085 | 0.344 | Vasodilator | 0.344 0.035 DBMET00829 | DBMET00829 | |
| 0.187 | 0.047 | 0.256 | Melanin inhibitor | 0.256 0.028 DBMET00829 | DBMET00829 | |
| 0.232 | 0.094 | 0.232 | Antioxidant | 0.229 0.096 DBMET00829 | ||
| 0.148 | 0.011 | 0.148 | Carbonic anhydrase stimulant | 0.092 0.021 DBMET00829 | ||
| 0.275 | 0.138 | 0.409 | Histamine release inhibitor | 0.409 0.071 DBMET00829 | DBMET00829 | |
| 0.161 | 0.027 | 0.161 | Heat shock protein 70 antagonist | 0.145 0.058 DBMET00829 | ||
| 0.145 | 0.011 | 0.153 | Glutamate release inhibitor | 0.153 0.009 DBMET00829 | DBMET00829 | |
| 0.148 | 0.017 | 0.222 | Alpha adrenoreceptor agonist | 0.222 0.007 DBMET00829 | DBMET00829 | |
| 0.135 | 0.005 | 0.175 | Beta 2 adrenoreceptor antagonist | 0.175 0.004 DBMET00829 | DBMET00829 | |
| 0.206 | 0.08 | 0.278 | Antimitotic | 0.278 0.05 DBMET00829 | DBMET00829 | |
| 0.137 | 0.016 | 0.263 | Glutamate decarboxylase inhibitor | 0.263 0.004 DBMET00829 | DBMET00829 | |
| 0.165 | 0.045 | 0.165 | Cholinergic antagonist | 0.164 0.045 DBMET00829 | ||
| 0.163 | 0.044 | 0.163 | Acetylcholine antagonist | 0.161 0.045 DBMET00829 | ||
| 0.159 | 0.04 | 0.192 | Antibacterial (Helicobacter pylori) | 0.192 0.024 DBMET00829 | DBMET00829 | |
| 0.142 | 0.025 | 0.166 | Electron transport complex I inhibitor | 0.166 0.014 DBMET00829 | DBMET00829 | |
| 0.232 | 0.114 | 0.232 | Insulysin inhibitor | 0.2 0.156 DBMET00829 | ||
| 0.226 | 0.109 | 0.343 | 5 Hydroxytryptamine uptake stimulant | 0.343 0.028 DBMET00829 | DBMET00829 | |
| 0.121 | 0.007 | 0.157 | GABA B receptor agonist | 0.157 0.004 DBMET00829 | DBMET00829 | |
| 0.159 | 0.048 | 0.159 | M18 aspartyl aminopeptidase inhibitor | 0.139 0.058 DBMET00829 | ||
| 0.131 | 0.021 | 0.131 | Glutamate (mGluR7) agonist | 0.129 0.023 DBMET00829 | ||
| 0.169 | 0.059 | 0.223 | Acetylcholine M1 receptor antagonist | 0.223 0.033 DBMET00829 | DBMET00829 | |
| 0.112 | 0.004 | 0.112 | Beta 2 adrenoreceptor agonist | 0.112 0.004 DBMET00829 | ||
| 0.12 | 0.013 | 0.171 | Alpha 1 adrenoreceptor agonist | 0.171 0.008 DBMET00829 | DBMET00829 | |
| 0.133 | 0.028 | 0.133 | Factor V inhibitor | |||
| 0.188 | 0.084 | 0.291 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.291 0.026 DBMET00829 | DBMET00829 | |
| 0.168 | 0.065 | 0.168 | Neurotensin receptor agonist | 0.163 0.074 DBMET00829 | ||
| 0.135 | 0.041 | 0.256 | GABA C receptor agonist | 0.256 0.013 DBMET00829 | DBMET00829 | |
| 0.17 | 0.08 | 0.219 | Succinate dehydrogenase inhibitor | 0.219 0.036 DBMET00829 | DBMET00829 | |
| 0.129 | 0.04 | 0.129 | Mediator release inhibitor | |||
| 0.203 | 0.119 | 0.488 | 5 Hydroxytryptamine release stimulant | 0.488 0.029 DBMET00829 | DBMET00829 | |
| 0.15 | 0.068 | 0.15 | Hemostatic | 0.119 0.116 DBMET00829 | ||
| 0.272 | 0.193 | 0.292 | Apoptosis agonist | 0.292 0.178 DBMET00829 | DBMET00829 | |
| 0.107 | 0.03 | 0.113 | Somatostatin 1 agonist | 0.113 0.026 DBMET00829 | DBMET00829 | |
| 0.08 | 0.004 | 0.089 | Beta adrenoreceptor agonist | 0.089 0.004 DBMET00829 | DBMET00829 | |
| 0.118 | 0.045 | 0.126 | Gastric antisecretory | 0.126 0.039 DBMET00829 | DBMET00829 | |
| 0.127 | 0.06 | 0.16 | Acetylcholine muscarinic antagonist | 0.16 0.038 DBMET00829 | DBMET00829 | |
| 0.122 | 0.055 | 0.149 | Photosensitizer | 0.149 0.031 DBMET00829 | DBMET00829 | |
| 0.097 | 0.032 | 0.111 | Keratolytic | 0.111 0.025 DBMET00829 | DBMET00829 | |
| 0.105 | 0.044 | 0.14 | Toll-Like receptor 3 antagonist | 0.14 0.018 DBMET00829 | DBMET00829 | |
| 0.084 | 0.023 | 0.084 | Maillard reaction inhibitor | 0.083 0.023 DBMET00829 | ||
| 0.179 | 0.118 | 0.179 | Platelet antagonist | |||
| 0.067 | 0.008 | 0.127 | Alpha 1d adrenoreceptor agonist | 0.127 0.003 DBMET00829 | DBMET00829 | |
| 0.099 | 0.04 | 0.165 | Carbonic anhydrase VI inhibitor | 0.165 0.018 DBMET00829 | DBMET00829 | |
| 0.212 | 0.155 | 0.32 | Cholesterol antagonist | 0.32 0.079 DBMET00829 | DBMET00829 | |
| 0.121 | 0.067 | 0.153 | Alkylator | 0.153 0.045 DBMET00829 | DBMET00829 | |
| 0.123 | 0.071 | 0.123 | Cathepsin H inhibitor | |||
| 0.106 | 0.054 | 0.125 | Anabolic | 0.125 0.035 DBMET00829 | DBMET00829 | |
| 0.093 | 0.042 | 0.196 | Carbonic anhydrase XIII inhibitor | 0.196 0.014 DBMET00829 | DBMET00829 | |
| 0.112 | 0.061 | 0.132 | Nav1.4 sodium channel blocker | 0.132 0.043 DBMET00829 | DBMET00829 | |
| 0.078 | 0.027 | 0.078 | Acetylcholine M3 receptor antagonist | 0.067 0.034 DBMET00829 | ||
| 0.086 | 0.039 | 0.151 | Histidine decarboxylase inhibitor | 0.151 0.019 DBMET00829 | DBMET00829 | |
| 0.176 | 0.129 | 0.261 | Tumour necrosis factor alpha release inhibitor | 0.261 0.07 DBMET00829 | DBMET00829 | |
| 0.089 | 0.043 | 0.098 | Estrogen-related receptor beta agonist | 0.098 0.027 DBMET00829 | DBMET00829 | |
| 0.169 | 0.124 | 0.529 | Aldehyde oxidase inhibitor | 0.529 0.029 DBMET00829 | DBMET00829 | |
| 0.09 | 0.046 | 0.09 | Histamine H2 receptor antagonist | 0.081 0.063 DBMET00829 | ||
| 0.09 | 0.047 | 0.09 | Vanilloid agonist | |||
| 0.149 | 0.106 | 0.149 | Platelet adhesion inhibitor | |||
| 0.09 | 0.048 | 0.09 | Factor XII inhibitor | |||
| 0.187 | 0.145 | 0.187 | Neuropeptide Y2 antagonist | 0.177 0.167 DBMET00829 | ||
| 0.055 | 0.015 | 0.055 | Plasmepsin II inhibitor | 0.049 0.019 DBMET00829 | ||
| 0.073 | 0.034 | 0.139 | 5 Hydroxytryptamine 2A agonist | 0.139 0.006 DBMET00829 | DBMET00829 | |
| 0.128 | 0.089 | 0.138 | Cell wall synthesis inhibitor | 0.138 0.077 DBMET00829 | DBMET00829 | |
| 0.118 | 0.08 | 0.139 | Alpha-N-acetylglucosaminidase inhibitor | 0.139 0.062 DBMET00829 | DBMET00829 | |
| 0.06 | 0.023 | 0.06 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.038 DBMET00829 | ||
| 0.07 | 0.034 | 0.07 | Neuraminidase inhibitor | 0.066 0.037 DBMET00829 | ||
| 0.09 | 0.055 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.095 0.047 DBMET00829 | DBMET00829 | |
| 0.092 | 0.058 | 0.092 | Polo-like kinase-1 inhibitor | 0.09 0.061 DBMET00829 | ||
| 0.132 | 0.098 | 0.132 | Anticoagulant | |||
| 0.04 | 0.007 | 0.124 | Alpha 1a adrenoreceptor agonist | 0.124 0.003 DBMET00829 | DBMET00829 | |
| 0.1 | 0.067 | 0.1 | Nav1.1 sodium channel blocker | |||
| 0.214 | 0.182 | 0.214 | Immunosuppressant | |||
| 0.063 | 0.03 | 0.079 | Ryanodine receptor antagonist | 0.079 0.01 DBMET00829 | DBMET00829 | |
| 0.139 | 0.107 | 0.155 | Nitric oxide antagonist | 0.155 0.091 DBMET00829 | DBMET00829 | |
| 0.066 | 0.034 | 0.066 | Acetylcholine M5 receptor antagonist | 0.061 0.041 DBMET00829 | ||
| 0.08 | 0.048 | 0.089 | Catalase inhibitor | 0.089 0.043 DBMET00829 | DBMET00829 | |
| 0.048 | 0.017 | 0.048 | Vascular adhesion protein 1 inhibitor | 0.046 0.019 DBMET00829 | ||
| 0.036 | 0.005 | 0.039 | Beta 1 adrenoreceptor agonist | 0.039 0.005 DBMET00829 | DBMET00829 | |
| 0.068 | 0.038 | 0.068 | Neuraminidase (influenza) inhibitor | 0.066 0.041 DBMET00829 | ||
| 0.145 | 0.116 | 0.182 | Phospholipase C inhibitor | 0.182 0.058 DBMET00829 | DBMET00829 | |
| 0.114 | 0.086 | 0.182 | Tubulin antagonist | 0.182 0.043 DBMET00829 | DBMET00829 | |
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | 0.055 0.038 DBMET00829 | ||
| 0.1 | 0.075 | 0.231 | Alpha 2b adrenoreceptor antagonist | 0.231 0.018 DBMET00829 | DBMET00829 | |
| 0.17 | 0.146 | 0.229 | DNA damaging | 0.229 0.093 DBMET00829 | DBMET00829 | |
| 0.097 | 0.074 | 0.158 | Ferrochelatase inhibitor | 0.158 0.035 DBMET00829 | DBMET00829 | |
| 0.041 | 0.02 | 0.041 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET00829 | ||
| 0.127 | 0.105 | 0.15 | Phospholipase A2 inhibitor | 0.15 0.074 DBMET00829 | DBMET00829 | |
| 0.081 | 0.06 | 0.081 | Glutathione S-transferase inhibitor | 0.075 0.069 DBMET00829 | ||
| 0.037 | 0.017 | 0.037 | Melatonin receptor 1A agonist | 0.034 0.022 DBMET00829 | ||
| 0.088 | 0.068 | 0.176 | HIV-1 integrase (Overall Integration) inhibitor | 0.176 0.017 DBMET00829 | DBMET00829 | |
| 0.056 | 0.039 | 0.144 | Alcohol oxidase inhibitor | 0.144 0.011 DBMET00829 | DBMET00829 | |
| 0.036 | 0.019 | 0.036 | Melatonin 1 agonist | |||
| 0.035 | 0.02 | 0.035 | Melatonin 2 agonist | |||
| 0.031 | 0.016 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.013 DBMET00829 | DBMET00829 | |
| 0.035 | 0.02 | 0.035 | Melatonin agonist | |||
| 0.059 | 0.046 | 0.059 | Acetylcholine M2 receptor antagonist | |||
| 0.038 | 0.025 | 0.038 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.03 | 0.016 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 DBMET00829 | ||
| 0.09 | 0.079 | 0.139 | GABA C receptor rho-1 antagonist | 0.139 0.027 DBMET00829 | DBMET00829 | |
| 0.029 | 0.019 | 0.029 | Melatonin antagonist | |||
| 0.138 | 0.128 | 0.232 | Anesthetic general | 0.232 0.059 DBMET00829 | DBMET00829 | |
| 0.035 | 0.025 | 0.069 | Phosphoglycerate kinase inhibitor | 0.069 0.01 DBMET00829 | DBMET00829 | |
| 0.029 | 0.019 | 0.029 | Thrombin receptor antagonist | |||
| 0.092 | 0.082 | 0.124 | Adenylate kinase inhibitor | 0.124 0.04 DBMET00829 | DBMET00829 | |
| 0.086 | 0.076 | 0.1 | Aminopeptidase B inhibitor | 0.1 0.065 DBMET00829 | DBMET00829 | |
| 0.043 | 0.034 | 0.068 | Mannosidase inhibitor | 0.068 0.013 DBMET00829 | DBMET00829 | |
| 0.135 | 0.126 | 0.137 | Hepatoprotectant | 0.137 0.124 DBMET00829 | DBMET00829 | |
| 0.018 | 0.009 | 0.018 | Calcium-sensing receptor antagonist | 0.017 0.01 DBMET00829 | ||
| 0.039 | 0.032 | 0.041 | Acetyl-CoA carboxylase inhibitor | 0.041 0.029 DBMET00829 | DBMET00829 | |
| 0.04 | 0.032 | 0.04 | Growth hormone release inhibitor | |||
| 0.077 | 0.071 | 0.117 | Ornithine decarboxylase inhibitor | 0.117 0.028 DBMET00829 | DBMET00829 | |
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET00829 | ||
| 0.05 | 0.045 | 0.069 | Alpha-mannosidase inhibitor | 0.069 0.017 DBMET00829 | DBMET00829 | |
| 0.105 | 0.101 | 0.105 | Bone formation stimulant | |||
| 0.065 | 0.061 | 0.067 | Cathepsin G inhibitor | 0.067 0.058 DBMET00829 | DBMET00829 | |
| 0.049 | 0.045 | 0.051 | Vanilloid 2 antagonist | 0.051 0.04 DBMET00829 | DBMET00829 | |
| 0.079 | 0.076 | 0.079 | Hematopoietic | |||
| 0.064 | 0.061 | 0.066 | Aminopeptidase I inhibitor | 0.066 0.058 DBMET00829 | DBMET00829 | |
| 0.018 | 0.017 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.006 DBMET00829 | DBMET00829 | |
| 0.041 | 0.041 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 DBMET00829 | DBMET00829 | |
| 0.136 | 0.137 | 0.188 | Non-steroidal antiinflammatory agent | 0.188 0.081 DBMET00829 | DBMET00829 | |
| 0.057 | 0.058 | 0.087 | Carbonic anhydrase V inhibitor | 0.087 0.032 DBMET00829 | DBMET00829 | |
| 0.031 | 0.034 | 0.038 | Somatostatin 1 antagonist | 0.038 0.027 DBMET00829 | DBMET00829 | |
| 0.062 | 0.065 | 0.083 | Exportin-1 inhibitor | 0.083 0.022 DBMET00829 | DBMET00829 | |
| 0.096 | 0.1 | 0.229 | Amylase inhibitor | 0.229 0.035 DBMET00829 | DBMET00829 | |
| 0.09 | 0.095 | 0.099 | Interleukin 1b antagonist | 0.099 0.082 DBMET00829 | DBMET00829 | |
| 0.008 | 0.013 | 0.016 | Beta 3 adrenoreceptor agonist | 0.016 0.005 DBMET00829 | DBMET00829 | |
| 0.032 | 0.038 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.023 DBMET00829 | DBMET00829 | |
| 0.05 | 0.058 | 0.143 | Alpha 2 adrenoreceptor agonist | 0.143 0.007 DBMET00829 | DBMET00829 | |
| 0.043 | 0.052 | 0.047 | Acyl-CoA dehydrogenase inhibitor | 0.047 0.046 DBMET00829 | DBMET00829 | |
| 0.04 | 0.048 | 0.062 | Carbonic anhydrase XIV inhibitor | 0.062 0.024 DBMET00829 | DBMET00829 | |
| 0.013 | 0.022 | 0.054 | Alpha 2a adrenoreceptor agonist | 0.054 0.004 DBMET00829 | DBMET00829 | |
| 0.077 | 0.086 | 0.103 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 DBMET00829 | DBMET00829 | |
| 0.063 | 0.072 | 0.11 | Glycine receptor agonist | 0.11 0.016 DBMET00829 | DBMET00829 | |
| 0.087 | 0.096 | 0.102 | Toll-Like receptor 4 antagonist | 0.102 0.066 DBMET00829 | DBMET00829 | |
| 0.121 | 0.131 | 0.148 | Interferon gamma antagonist | 0.148 0.081 DBMET00829 | DBMET00829 | |
| 0.088 | 0.1 | 0.106 | Protein kinase C gamma inhibitor | 0.106 0.067 DBMET00829 | DBMET00829 | |
| 0.056 | 0.068 | 0.079 | Carbonic anhydrase VA inhibitor | 0.079 0.037 DBMET00829 | DBMET00829 | |
| 0.078 | 0.091 | 0.171 | Alpha 2c adrenoreceptor antagonist | 0.171 0.025 DBMET00829 | DBMET00829 | |
| 0.019 | 0.033 | 0.036 | Somatostatin 5 antagonist | 0.036 0.02 DBMET00829 | DBMET00829 | |
| 0.032 | 0.049 | 0.046 | Sphingosine 1-phosphate receptor 1 agonist | 0.046 0.024 DBMET00829 | DBMET00829 | |
| 0.046 | 0.064 | 0.099 | Purinergic P2X2 antagonist | 0.099 0.03 DBMET00829 | DBMET00829 | |
| 0.059 | 0.077 | 0.083 | Glutamate dehydrogenase inhibitor | 0.083 0.042 DBMET00829 | DBMET00829 | |
| 0.017 | 0.036 | 0.039 | Uridine phosphorylase inhibitor | 0.039 0.012 DBMET00829 | DBMET00829 | |
| 0.135 | 0.154 | 0.166 | Hypolipemic | 0.166 0.122 DBMET00829 | DBMET00829 | |
| 0.077 | 0.098 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.136 0.018 DBMET00829 | DBMET00829 | |
| 0.034 | 0.055 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 DBMET00829 | DBMET00829 | |
| 0.042 | 0.065 | 0.048 | Factor III inhibitor | 0.048 0.041 DBMET00829 | DBMET00829 | |
| 0.086 | 0.109 | 0.159 | Cholesterol synthesis inhibitor | 0.159 0.04 DBMET00829 | DBMET00829 | |
| 0.074 | 0.097 | 0.1 | Topoisomerase I inhibitor | 0.1 0.07 DBMET00829 | DBMET00829 | |
| 0.097 | 0.12 | 0.113 | Lipid peroxidase inhibitor | 0.113 0.101 DBMET00829 | DBMET00829 | |
| 0.015 | 0.039 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | 0.02 0.016 DBMET00829 | DBMET00829 | |
| 0.022 | 0.048 | 0.03 | Hedgehog signaling activator | 0.03 0.013 DBMET00829 | DBMET00829 | |
| 0.059 | 0.085 | 0.093 | GABA aminotransferase inhibitor | 0.093 0.033 DBMET00829 | DBMET00829 | |
| 0.035 | 0.062 | 0.067 | Carbonic anhydrase VB inhibitor | 0.067 0.029 DBMET00829 | DBMET00829 | |
| 0.034 | 0.061 | 0.047 | Ornithine carbamoyltransferase inhibitor | 0.047 0.042 DBMET00829 | DBMET00829 | |
| 0.027 | 0.056 | 0.047 | Urokinase inhibitor | 0.047 0.034 DBMET00829 | DBMET00829 | |
| 0.04 | 0.071 | 0.058 | Leukotriene B4 antagonist | 0.058 0.03 DBMET00829 | DBMET00829 | |
| 0.14 | 0.172 | 0.229 | Cyclic AMP phosphodiesterase inhibitor | 0.229 0.075 DBMET00829 | DBMET00829 | |
| 0.051 | 0.083 | 0.109 | Na+ K+ transporting ATPase inhibitor | 0.109 0.024 DBMET00829 | DBMET00829 | |
| 0.025 | 0.057 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.018 DBMET00829 | DBMET00829 | |
| 0.081 | 0.115 | 0.142 | GABA C receptor antagonist | 0.142 0.035 DBMET00829 | DBMET00829 | |
| 0.087 | 0.122 | 0.109 | Acetylcholine release stimulant | 0.109 0.068 DBMET00829 | DBMET00829 | |
| 0.069 | 0.104 | 0.115 | NADH dehydrogenase inhibitor | 0.115 0.031 DBMET00829 | DBMET00829 | |
| 0.053 | 0.088 | 0.089 | Glutamate (mGluR7) antagonist | 0.089 0.018 DBMET00829 | DBMET00829 | |
| 0.156 | 0.192 | 0.216 | DNA synthesis inhibitor | 0.216 0.1 DBMET00829 | DBMET00829 | |
| 0.06 | 0.096 | 0.072 | Interferon agonist | 0.072 0.067 DBMET00829 | DBMET00829 | |
| 0.056 | 0.092 | 0.121 | Calcium antagonist | 0.121 0.034 DBMET00829 | DBMET00829 | |
| 0.068 | 0.105 | 0.102 | Triose-phosphate isomerase inhibitor | 0.102 0.046 DBMET00829 | DBMET00829 | |
| 0.01 | 0.05 | 0.02 | Factor IX inhibitor | 0.02 0.012 DBMET00829 | DBMET00829 | |
| 0.084 | 0.123 | 0.12 | Microtubule formation inhibitor | 0.12 0.06 DBMET00829 | DBMET00829 | |
| 0.031 | 0.072 | 0.045 | Kainate receptor agonist | 0.045 0.02 DBMET00829 | DBMET00829 | |
| 0.035 | 0.079 | 0.047 | Factor IXa inhibitor | 0.047 0.042 DBMET00829 | DBMET00829 | |
| 0.129 | 0.174 | 0.19 | Neurotrophic factor enhancer | 0.19 0.087 DBMET00829 | DBMET00829 | |
| 0.067 | 0.113 | 0.098 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 DBMET00829 | DBMET00829 | |
| 0.053 | 0.101 | 0.081 | Calcium channel P-type blocker | 0.081 0.014 DBMET00829 | DBMET00829 | |
| 0.018 | 0.066 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET00829 | DBMET00829 | |
| 0.072 | 0.121 | 0.159 | Cystathionine beta-synthase inhibitor | 0.159 0.037 DBMET00829 | DBMET00829 | |
| 0.054 | 0.102 | 0.074 | Acetylcholine nicotinic antagonist | 0.074 0.061 DBMET00829 | DBMET00829 | |
| 0.017 | 0.067 | 0.041 | Cholesterol ester transfer protein antagonist | 0.041 0.012 DBMET00829 | DBMET00829 | |
| 0.034 | 0.085 | 0.059 | Dopamine beta hydroxylase inhibitor | 0.059 0.017 DBMET00829 | DBMET00829 | |
| 0.027 | 0.078 | 0.041 | Sphingosine 1-phosphate receptor agonist | 0.041 0.035 DBMET00829 | DBMET00829 | |
| 0.049 | 0.102 | 0.152 | Alpha 2a adrenoreceptor antagonist | 0.152 0.022 DBMET00829 | DBMET00829 | |
| 0.023 | 0.076 | 0.051 | Dopamine D5 agonist | 0.051 0.017 DBMET00829 | DBMET00829 | |
| 0.04 | 0.094 | 0.071 | Leukotriene antagonist | 0.071 0.039 DBMET00829 | DBMET00829 | |
| 0.034 | 0.087 | 0.061 | Aconitate hydratase inhibitor | 0.061 0.025 DBMET00829 | DBMET00829 | |
| 0.111 | 0.165 | 0.138 | Tumour necrosis factor antagonist | 0.138 0.116 DBMET00829 | DBMET00829 | |
| 0.056 | 0.11 | 0.095 | Myeloperoxidase inhibitor | 0.095 0.042 DBMET00829 | DBMET00829 | |
| 0.03 | 0.086 | 0.056 | Prostaglandin EP2 antagonist | 0.056 0.045 DBMET00829 | DBMET00829 | |
| 0.067 | 0.125 | 0.085 | D-Ala-D-Ala ligase inhibitor | 0.085 0.055 DBMET00829 | DBMET00829 | |
| 0.039 | 0.1 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.039 DBMET00829 | DBMET00829 | |
| 0.077 | 0.139 | 0.116 | DOPA decarboxylase inhibitor | 0.116 0.05 DBMET00829 | DBMET00829 | |
| 0.033 | 0.096 | 0.064 | Carbamoyl phosphate synthetase inhibitor | 0.064 0.039 DBMET00829 | DBMET00829 | |
| 0.024 | 0.087 | 0.043 | Potassium channel Kv1.3 blocker | 0.043 0.038 DBMET00829 | DBMET00829 | |
| 0.025 | 0.091 | 0.038 | Glutamate (mGluR8) agonist | 0.038 0.026 DBMET00829 | DBMET00829 | |
| 0.014 | 0.084 | 0.061 | Dopamine D3 agonist | 0.061 0.014 DBMET00829 | DBMET00829 | |
| 0.029 | 0.099 | 0.049 | Potassium channel (Inward rectifier) blocker | 0.049 0.035 DBMET00829 | DBMET00829 | |
| 0.049 | 0.121 | 0.137 | Alpha adrenoreceptor antagonist | 0.137 0.041 DBMET00829 | DBMET00829 | |
| 0.023 | 0.096 | 0.073 | Alpha 1d adrenoreceptor antagonist | 0.073 0.033 DBMET00829 | DBMET00829 | |
| 0.049 | 0.123 | 0.155 | Alpha 2 adrenoreceptor antagonist | 0.155 0.026 DBMET00829 | DBMET00829 | |
| 0.066 | 0.142 | 0.095 | Xanthine oxidase inhibitor | 0.095 0.065 DBMET00829 | DBMET00829 | |
| 0.051 | 0.129 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.056 DBMET00829 | DBMET00829 | |
| 0.048 | 0.129 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.035 DBMET00829 | DBMET00829 | |
| 0.038 | 0.119 | 0.08 | Porphobilinogen synthase inhibitor | 0.08 0.047 DBMET00829 | DBMET00829 | |
| 0.118 | 0.201 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.057 DBMET00829 | DBMET00829 | |
| 0.132 | 0.216 | 0.204 | 5 Hydroxytryptamine 1E antagonist | 0.204 0.126 DBMET00829 | DBMET00829 | |
| 0.084 | 0.171 | 0.115 | Transcription factor STAT6 inhibitor | 0.115 0.069 DBMET00829 | DBMET00829 | |
| 0.032 | 0.121 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 DBMET00829 | DBMET00829 | |
| 0.03 | 0.12 | 0.061 | Phosphofructokinase-1 inhibitor | 0.061 0.056 DBMET00829 | DBMET00829 | |
| 0.023 | 0.114 | 0.044 | Dihydrofolate reductase inhibitor | 0.044 0.03 DBMET00829 | DBMET00829 | |
| 0.046 | 0.138 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.04 DBMET00829 | DBMET00829 | |
| 0.103 | 0.196 | 0.157 | CF transmembrane conductance regulator agonist | 0.157 0.064 DBMET00829 | DBMET00829 | |
| 0.006 | 0.099 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.019 0.013 DBMET00829 | DBMET00829 | |
| 0.073 | 0.166 | 0.107 | TRPA1 agonist | 0.107 0.076 DBMET00829 | DBMET00829 | |
| 0.145 | 0.241 | 0.182 | 5 Hydroxytryptamine 3E antagonist | 0.182 0.099 DBMET00829 | DBMET00829 | |
| 0.03 | 0.127 | 0.089 | Alpha 1 adrenoreceptor antagonist | 0.089 0.048 DBMET00829 | DBMET00829 | |
| 0.026 | 0.128 | 0.085 | Alpha 1b adrenoreceptor antagonist | 0.085 0.043 DBMET00829 | DBMET00829 | |
| 0.052 | 0.155 | 0.096 | Prolactin inhibitor | 0.096 0.06 DBMET00829 | DBMET00829 | |
| 0.093 | 0.199 | 0.134 | GABA C receptor rho-2 antagonist | 0.134 0.099 DBMET00829 | DBMET00829 | |
| 0.021 | 0.135 | 0.081 | 5 Hydroxytryptamine 2 agonist | 0.081 0.015 DBMET00829 | DBMET00829 | |
| 0.051 | 0.168 | 0.169 | MAO inhibitor | 0.169 0.052 DBMET00829 | DBMET00829 | |
| 0.105 | 0.225 | 0.135 | ATPase inhibitor | 0.135 0.13 DBMET00829 | DBMET00829 | |
| 0.042 | 0.162 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.054 DBMET00829 | DBMET00829 | |
| 0.046 | 0.167 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.118 0.025 DBMET00829 | DBMET00829 | |
| 0.087 | 0.21 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.102 DBMET00829 | DBMET00829 | |
| 0.053 | 0.184 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.059 DBMET00829 | DBMET00829 | |
| 0.008 | 0.145 | 0.019 | Alpha 2b adrenoreceptor agonist | 0.019 0.013 DBMET00829 | DBMET00829 | |
| 0.031 | 0.17 | 0.055 | Purinergic P2X1 antagonist | 0.055 0.051 DBMET00829 | DBMET00829 | |
| 0.051 | 0.191 | 0.115 | Nitric-oxide synthase inhibitor | 0.115 0.041 DBMET00829 | DBMET00829 | |
| 0.149 | 0.29 | 0.243 | GABA C receptor rho-3 antagonist | 0.243 0.161 DBMET00829 | DBMET00829 | |
| 0.051 | 0.193 | 0.09 | Bile acid receptor antagonist | 0.09 0.074 DBMET00829 | DBMET00829 | |
| 0.045 | 0.19 | 0.093 | Creatine kinase inhibitor | 0.093 0.068 DBMET00829 | DBMET00829 | |
| 0.131 | 0.28 | 0.185 | Transcription factor STAT inhibitor | 0.185 0.16 DBMET00829 | DBMET00829 | |
| 0.036 | 0.186 | 0.137 | Protein kinase B gamma inhibitor | 0.137 0.02 DBMET00829 | DBMET00829 | |
| 0.065 | 0.219 | 0.109 | Interleukin 4 antagonist | 0.109 0.103 DBMET00829 | DBMET00829 | |
| 0.073 | 0.231 | 0.147 | Arachidonic acid antagonist | 0.147 0.091 DBMET00829 | DBMET00829 | |
| 0.034 | 0.202 | 0.074 | Macrophage migration inhibitory factor inhibitor | 0.074 0.059 DBMET00829 | DBMET00829 | |
| 0.009 | 0.179 | 0.031 | Catechol O-methyltransferase inhibitor | 0.031 0.026 DBMET00829 | DBMET00829 | |
| 0.017 | 0.232 | 0.067 | Dopamine agonist | 0.067 0.046 DBMET00829 | DBMET00829 | |
| 0.089 | 0.318 | 0.178 | Lipoxygenase inhibitor | 0.178 0.166 DBMET00829 | DBMET00829 | |
| 0.105 | 0.342 | 0.169 | RNA-directed DNA polymerase inhibitor | 0.169 0.154 DBMET00829 | DBMET00829 | |
| 0.038 | 0.298 | 0.118 | Nav1.6 sodium channel blocker | 0.118 0.1 DBMET00829 | DBMET00829 | |
| 0.014 | 0.297 | 0.054 | Phenylethanolamine N methyltransferase inhibitor | 0.054 0.011 DBMET00829 | DBMET00829 | |
| 0.015 | 0.317 | 0.093 | DNA gyrase inhibitor | 0.093 0.02 DBMET00829 | DBMET00829 | |
| 0.021 | 0.368 | 0.083 | Protein kinase C delta inhibitor | 0.083 0.073 DBMET00829 | DBMET00829 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |